FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3035261315> ?p ?o ?g. }

• W3035261315 endingPage "106397" @default.
• W3035261315 startingPage "106397" @default.
• W3035261315 abstract "Magnetic resonance–guided laser interstitial thermal therapy (MRgLiTT) is a minimally invasive treatment for drug-resistant epilepsies (DRE), and stereoelectroencephalography-guided radiofrequency thermocoagulation (SEEG-RFTC) is also reported as a minimally invasive treatment in some cases with DRE. This study aimed to undertake a meta-analysis to assess the effectiveness and safety of the two approaches in treating DRE. Databases, including PubMed, Embase, and Cochrane, were searched systematically up to November 2019. Our primary objective was to estimate the percentage of postoperative freedom from seizures and complications after MRgLiTT and SEEG-RFTC. The secondary objective was to estimate the rate of freedom from seizure after dividing the patients into groups according to the etiology of the epilepsy. Twenty-six studies, with a total number of 804 patients, were identified, 16 studies with MRgLiTT (414 patients) and 10 with SEEG-RFTC (390 patients). In total, significant difference was found in the postoperative rate of freedom from seizure between patients with MRgLiTT (65 %; 95 % CI 56–74 %) and those with SEEG-RFTC (23 %; 95 % CI 10–39 %) (P = 0.00), and there was high heterogeneity across groups. After dividing the patients according to etiology, those with MRgLiTT in both the hypothalamic hamartoma group (99 %; 95 % CI 92 %–100 %) and the temporal lobe epilepsy group (59 %; 95 % CI 53 %–65 %) achieved great efficacy and low heterogeneity, and patients with temporal lobe epilepsy and mesial temporal sclerosis (MTS) did not achieve better seizure control than non-MTS patients did (OR = 1.46; 95 % CI [0.88, 2.41]; P = 0.142). For the patients treated with SEEG-RFTC, those in the periventricular nodular heterotopias group obtained the highest percentage of freedom from seizure (56 %; 95 % CI 23 %–86 %). The overall complication rate across all samples was low in the two approaches (5%; 95 % CI 3%–8%). MRgLiTT and SEEG-RFTC are both safe, minimally invasive treatments for patients with DRE. Patients treated with MRgLiTT had an overall higher postoperative rate of freedom from seizure than those treated with SEEG-RFTC." @default.
• W3035261315 created "2020-06-19" @default.
• W3035261315 creator A5021979312 @default.
• W3035261315 creator A5023009418 @default.
• W3035261315 creator A5024601689 @default.
• W3035261315 creator A5037720250 @default.
• W3035261315 creator A5042463849 @default.
• W3035261315 creator A5047118248 @default.
• W3035261315 creator A5049317673 @default.
• W3035261315 creator A5083662293 @default.
• W3035261315 date "2020-10-01" @default.
• W3035261315 modified "2023-10-13" @default.
• W3035261315 title "Magnetic resonance–guided laser interstitial thermal therapy versus stereoelectroencephalography-guided radiofrequency thermocoagulation for drug-resistant epilepsy: A systematic review and meta-analysis" @default.
• W3035261315 cites W1171447113 @default.
• W3035261315 cites W1768503955 @default.
• W3035261315 cites W1861687490 @default.
• W3035261315 cites W1952711476 @default.
• W3035261315 cites W1963494045 @default.
• W3035261315 cites W1964389368 @default.
• W3035261315 cites W1967864491 @default.
• W3035261315 cites W1992021255 @default.
• W3035261315 cites W2017044005 @default.
• W3035261315 cites W2020888576 @default.
• W3035261315 cites W2037486347 @default.
• W3035261315 cites W2047155085 @default.
• W3035261315 cites W2052569134 @default.
• W3035261315 cites W2052656085 @default.
• W3035261315 cites W2075141388 @default.
• W3035261315 cites W2075373783 @default.
• W3035261315 cites W2104153248 @default.
• W3035261315 cites W2133564174 @default.
• W3035261315 cites W2139403294 @default.
• W3035261315 cites W2157823046 @default.
• W3035261315 cites W2201479603 @default.
• W3035261315 cites W2220931529 @default.
• W3035261315 cites W2317495993 @default.
• W3035261315 cites W2327304918 @default.
• W3035261315 cites W2523173178 @default.
• W3035261315 cites W2524577136 @default.
• W3035261315 cites W2527445323 @default.
• W3035261315 cites W2556511715 @default.
• W3035261315 cites W2585597192 @default.
• W3035261315 cites W2594920528 @default.
• W3035261315 cites W2604288576 @default.
• W3035261315 cites W2612003979 @default.
• W3035261315 cites W2623957986 @default.
• W3035261315 cites W2726492075 @default.
• W3035261315 cites W2733477457 @default.
• W3035261315 cites W2745000643 @default.
• W3035261315 cites W2746381663 @default.
• W3035261315 cites W2753896599 @default.
• W3035261315 cites W2762548327 @default.
• W3035261315 cites W2762661445 @default.
• W3035261315 cites W2769394528 @default.
• W3035261315 cites W2769654354 @default.
• W3035261315 cites W2781435253 @default.
• W3035261315 cites W2783427244 @default.
• W3035261315 cites W2789679712 @default.
• W3035261315 cites W2791329727 @default.
• W3035261315 cites W2791787568 @default.
• W3035261315 cites W2794091721 @default.
• W3035261315 cites W2794750553 @default.
• W3035261315 cites W2794938125 @default.
• W3035261315 cites W2796228083 @default.
• W3035261315 cites W2808266286 @default.
• W3035261315 cites W2810771680 @default.
• W3035261315 cites W2851254118 @default.
• W3035261315 cites W2885469058 @default.
• W3035261315 cites W2887934545 @default.
• W3035261315 cites W2897287208 @default.
• W3035261315 cites W2898557478 @default.
• W3035261315 cites W2898743526 @default.
• W3035261315 cites W2906474944 @default.
• W3035261315 cites W2910402718 @default.
• W3035261315 cites W2921259546 @default.
• W3035261315 cites W2923776826 @default.
• W3035261315 cites W2944835261 @default.
• W3035261315 cites W2955166585 @default.
• W3035261315 cites W2966941474 @default.
• W3035261315 cites W2970320444 @default.
• W3035261315 cites W4245932665 @default.
• W3035261315 cites W4317855895 @default.
• W3035261315 doi "https://doi.org/10.1016/j.eplepsyres.2020.106397" @default.
• W3035261315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32590289" @default.
• W3035261315 hasPublicationYear "2020" @default.
• W3035261315 type Work @default.
• W3035261315 sameAs 3035261315 @default.
• W3035261315 citedByCount "14" @default.
• W3035261315 countsByYear W30352613152021 @default.
• W3035261315 countsByYear W30352613152022 @default.
• W3035261315 countsByYear W30352613152023 @default.
• W3035261315 crossrefType "journal-article" @default.
• W3035261315 hasAuthorship W3035261315A5021979312 @default.
• W3035261315 hasAuthorship W3035261315A5023009418 @default.
• W3035261315 hasAuthorship W3035261315A5024601689 @default.
• W3035261315 hasAuthorship W3035261315A5037720250 @default.
• W3035261315 hasAuthorship W3035261315A5042463849 @default.
• W3035261315 hasAuthorship W3035261315A5047118248 @default.

• next